Central Retinal Vein Occlusion: Clinical Trials

10 trials for Central Retinal Vein Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown. 10 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 5, Unknown 5

Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections
Ophthalmologic exam at inclusion and 12 months after CRVO, Treatment standardization with aflibercept - Central Retinal Vein Occlusion
Not applicableCompletedFondation Ophtalmologique Adolphe de Rothschild602021-03-242025-04-30
Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
Bevacizumab Ophthalmic and Intravitreal Dexamethasone., Bevacizumab Ophthalmic. - Central Retinal Vein Occlusion
Not applicableUnknownHe Eye Hospital1002020-10-172020-10-26
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Free Eye Screenings, Enhanced Intervention, Usual Care - Glaucoma, Glaucoma Suspect
Not applicableCompletedWills Eye9062014-09-012022-08-22
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
ranibizumab - Macular Edema, Branch Retinal Vein Occlusion
Not applicableUnknownTokyo Medical University1002013-12-012014-06-23
Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO
Ranibizumab - Central Retinal Vein Occlusion
Not applicableUnknownMie University302013-12-012014-03-19
Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival
Xylocaine 2% Injectable Anesthetic, Proparacaine Hydrochloride 0.5% Drop, Tetravisc 0.5% Gel - Age-related Macular Degeneration, Central Retinal Vein Occlusion
Not applicableCompletedRetina Vitreous Associates of Florida572012-07-012014-04-21
A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye
Conj flora Antibiotic resistance - Central Retinal Vein Occlusion, Choroidal Neovascularization
Not applicableUnknownMid Atlantic Retina302011-08-012012-02-13
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Ozurdex, Avastin - Macular Edema, Central Retinal Vein Occlusion
Not applicableCompletedLong Island Vitreoretinal Consultants272010-09-012018-04-03
Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion
Retinal endo vascular surgery - Central Retinal Vein Occlusion
Not applicableUnknownHadassah Medical Organization102006-10-012006-10-04
A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion
fluocinolone acetonide (Retisert Implant, Bausch and Lomb) - Central Retinal Vein Occlusion
Not applicableCompletedGlenn Jaffe292002-10-012014-08-06

Narrower conditions

Retinal Vein Occlusion (10)  ·  Macular Degeneration (3)  ·  Macular Edema (3)  ·  Cataract (1)  ·  Choroidal Neovascularization (1)  ·  Diabetic Retinopathy (1)  ·  Glaucoma (1)  ·  Ocular Hypertension (1)  ·  Pain (1)  ·  Retinal Artery Occlusion (1)  ·  Vision Disorders (1)

Broader conditions

Cardiovascular Diseases (10)  ·  Embolism and Thrombosis (10)  ·  Eye Diseases (10)  ·  Retinal Diseases (10)  ·  Thrombosis (10)  ·  Vascular Diseases (10)  ·  Venous Thrombosis (10)  ·  Retinal Degeneration (6)  ·  Macular Degeneration (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neurologic Manifestations (2)  ·  Signs and Symptoms (2)  ·  Arterial Occlusive Diseases (1)  ·  Choroid Diseases (1)  ·  Diabetes Complications (1)

Interventions

Bevacizumab (3)  ·  Ranibizumab (3)  ·  Calcium Dobesilate (2)  ·  aflibercept (2)  ·  Anesthesia (1)  ·  Anesthetics (1)  ·  Anti-Inflammatory Agents (1)  ·  Dexamethasone (1)  ·  Gels (1)  ·  Ketorolac (1)  ·  Lidocaine (1)  ·  Tetracaine (1)  ·  proxymetacaine (1)

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Glenn Jaffe (1)  ·  Hadassah Medical Organization (1)  ·  He Eye Hospital (1)  ·  Long Island Vitreoretinal Consultants (1)  ·  Mid Atlantic Retina (1)  ·  Mie University (1)  ·  Retina Vitreous Associates of Florida (1)  ·  Tokyo Medical University (1)  ·  Wills Eye (1)

Countries

United States (5)  ·  Japan (2)  ·  China (1)  ·  France (1)

Top investigators

Emmanuel E Pazo, M.D., Ph.D. (1)  ·  Glenn J Jaffe, MD (1)  ·  Hidetaka Noma, MD (1)  ·  Jason Hsu, MD (1)  ·  Julia A Haller, MD (1)  ·  Jun Li, M.D., Ph.D. (1)  ·  L. J Katz, MD (1)  ·  Lisa A Hark, PhD (1)  ·  Mineo Kondo, MD, PhD (1)  ·  Steven M Cohen, MD (1)  ·  Vincent A Deramo, M.D (1)  ·  Wei He, M.D., Ph.D. (1)

Results publications

PMID 28673747, PMID 30770354, PMID 34014814